Scholarlink

Background <p>Endophytic bacteria are increasingly recognized as a promising source of biologically active secondary metabolites with potential biomedical applications. This study aimed to evaluate the antimicrobial and anticancer activities of secondary metabolite extracts derived from endophytic bacteria associated with <i>Echinacea purpura</i> (<i>E. purpurea</i>) and <i>Calendula officinalis</i> (<i>C. officinalis</i>).</p> Methods <p>Bacterial endophytes were identified using phenotypic characterization and 16&#xa0;S rRNA gene sequencing. Secondary metabolites were extracted using ethyl acetate and evaluated for antimicrobial activity using agar well diffusion and broth microdilution assays, including determination of minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC). Cytotoxic and apoptosis-inducing effects were assessed using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) and flow cytometry assays. Chemical profiling was performed using Fourier-transform infrared spectroscopy (FTIR) and gas chromatography–mass spectrometry (GC–MS).</p> Results <p>Three isolates (SM.Ep01, SM.Co01, and SM.Co05) demonstrated measurable antimicrobial activity, predominantly against Gram-positive bacteria. SEM analysis revealed structural alterations in bacterial cells following treatment. Crude metabolite extracts induced dose-dependent cytotoxicity and apoptosis in cancer cell lines. FTIR and GC–MS analyses revealed diverse functional groups and tentatively identified compounds previously associated with biological activity.</p> Conclusion <p>These findings provide preliminary evidence that endophytic bacteria associated with <i>E. purpurea</i> and <i>C. officinalis</i> may represent potential sources of biologically active metabolites.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Isolation and characterization of endophytic bacteria from Echinacea purpurea and Calendula officinalis with antimicrobial and anticancer activities

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月30日

查看全文
  • Razieh Mohseni,
  • Hasan Shojaei,
  • Mohammad Sadegh Damavandi

摘要

Background

Endophytic bacteria are increasingly recognized as a promising source of biologically active secondary metabolites with potential biomedical applications. This study aimed to evaluate the antimicrobial and anticancer activities of secondary metabolite extracts derived from endophytic bacteria associated with Echinacea purpura (E. purpurea) and Calendula officinalis (C. officinalis).

Methods

Bacterial endophytes were identified using phenotypic characterization and 16 S rRNA gene sequencing. Secondary metabolites were extracted using ethyl acetate and evaluated for antimicrobial activity using agar well diffusion and broth microdilution assays, including determination of minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum fungicidal concentration (MFC). Cytotoxic and apoptosis-inducing effects were assessed using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT) and flow cytometry assays. Chemical profiling was performed using Fourier-transform infrared spectroscopy (FTIR) and gas chromatography–mass spectrometry (GC–MS).

Results

Three isolates (SM.Ep01, SM.Co01, and SM.Co05) demonstrated measurable antimicrobial activity, predominantly against Gram-positive bacteria. SEM analysis revealed structural alterations in bacterial cells following treatment. Crude metabolite extracts induced dose-dependent cytotoxicity and apoptosis in cancer cell lines. FTIR and GC–MS analyses revealed diverse functional groups and tentatively identified compounds previously associated with biological activity.

Conclusion

These findings provide preliminary evidence that endophytic bacteria associated with E. purpurea and C. officinalis may represent potential sources of biologically active metabolites.